Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Operating Leases (2019 - 2025)

OptimizeRx (OPRX) has disclosed Operating Leases for 7 consecutive years, with $234000.0 as the latest value for Q4 2025.

  • Quarterly Operating Leases rose 11.96% to $234000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $234000.0 through Dec 2025, up 11.96% year-over-year, with the annual reading at $234000.0 for FY2025, 11.96% up from the prior year.
  • Operating Leases hit $234000.0 in Q4 2025 for OptimizeRx, down from $300000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $548000.0 in Q2 2025 to a low of $14019.0 in Q2 2023.
  • Historically, Operating Leases has averaged $242827.2 across 5 years, with a median of $239363.0 in 2021.
  • Biggest five-year swings in Operating Leases: tumbled 92.61% in 2023 and later skyrocketed 1833.09% in 2024.
  • Year by year, Operating Leases stood at $236726.0 in 2021, then crashed by 38.95% to $144532.0 in 2022, then soared by 156.69% to $371000.0 in 2023, then crashed by 43.67% to $209000.0 in 2024, then grew by 11.96% to $234000.0 in 2025.
  • Business Quant data shows Operating Leases for OPRX at $234000.0 in Q4 2025, $300000.0 in Q3 2025, and $548000.0 in Q2 2025.